semaglutide for weight loss san francisco Our Weight Management Program By the Numbers Medi-Cal should cover GLP-1 medications

Like the forecast for supply is that it takes these companies quite a bit of time to build up manufacturing capacity

In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future

For patients with type 2 diabetes, the American Diabetes Association recommends checking HbA1c every three months until glycemic targets are achieved, then at least twice yearly thereafter

To help members see progress, were introducing a reimagined digital experience that combines decades of behavior-change expertise with new technology to give members a clearer, more personalized view of their weight health and help them be more successful in reaching and sustaining their goals